Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9Y5N6
UPID:
ORC6_HUMAN
Alternative names:
-
Alternative UPACC:
Q9Y5N6; B3KN89
Background:
Origin recognition complex subunit 6 plays a pivotal role in DNA replication initiation, binding replication origins in an ATP-dependent manner. Despite the lack of identified specific DNA sequences for replication origins, this protein's involvement in assembling the pre-replication complex is crucial for DNA synthesis onset. It notably does not interact with certain histone trimethylation marks, indicating specificity in its function.
Therapeutic significance:
Linked to Meier-Gorlin syndrome 3, a condition characterized by growth retardation and skeletal anomalies, understanding the role of Origin recognition complex subunit 6 could open doors to potential therapeutic strategies.